Madrigal Pharmaceuticals (MDGL) Asset Utilization Ratio (2011 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Asset Utilization Ratio of 0.91 for Q1 2026, up 192.54% year-over-year from 0.31 in Q1 2025, and up 24.58% quarter-over-quarter from 0.73 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 6 years of Asset Utilization Ratio data on file, last reported at 0.91 in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.91, up 192.54% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.91 (up 192.54% YoY), and the FY2025 annual result was 0.83, up 288.97% from the prior year.
- Asset Utilization Ratio advanced to 0.91 in Q1 2026 per MDGL's latest filing, from 0.73 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.91 in Q1 2026 and troughed at 0.01 in Q2 2024.
- A 3-year average of 0.42 and a median of 0.41 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio soared 3719.66% in 2025, then surged 192.54% in 2026.
- A 3-year view of Asset Utilization Ratio shows it stood at 0.17 in 2024, then surged by 329.27% to 0.73 in 2025, then climbed by 24.58% to 0.91 in 2026.
- Business Quant data shows MDGL's Asset Utilization Ratio at 0.91 in Q1 2026, 0.73 in Q4 2025, and 0.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | 0.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.91 |
| Dec 31, 2025 | 0.73 |
| Sep 30, 2025 | 0.62 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.17 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.01 |
| Jun 30, 2013 | 0.00 |
| Sep 30, 2012 | 0.07 |
| Jun 30, 2012 | 0.08 |
| Mar 31, 2012 | 0.08 |
| Dec 31, 2011 | 0.11 |
| Sep 30, 2011 | 0.10 |